The treatment of chronic pancreatitis

Hung Hsu Hung, Cheng Hsi Su, Shou Dong Lee

研究成果: Article同行評審

摘要

The traditional definition of chronic pancreatitis (CP) has been permanent and irreversible damage to the pancreas. The damages resulted in both structure and functional abnormalities, including chronic inflammation, fibrosis, steatorrhea and diabetes. The treatment of CP is mainly focused on the symptoms. Abdominal pain is the most common clinical problem and decreased the quality of life. The treatments for pain control included analgesics, antioxidants, pancreatic enzyme therapy, octreotide and endoscopic treatment. The general goal of endoscopic therapy is to improve drainage of the pancreatic duct by relieving ductal obstruction. However, endoscopic treatment is limited due to the pancreatic ductal anatomy. In recent years, the combination of endoscopic treatment and extracorporeal shock-wave lithotripsy (ESWL) improved the success rate of pancreatic duct stone removal and pain control. Maldigestion occurred when approximately 10% of the normal pancreatic output of lipase. Pancreatic enzyme therapy is mainly the solution for steatorrhea. The failure of enzyme replacement therapy is multi-factorial, including inadequate dose, noncompliance, inadequate formulation, and associated with other underlying disease. Diabetes mellitus is an independent risk factor of mortality in chronic pancreatitis. The dose of insulin in chronic pancreatitis is usually lower than insulin-resistant type 2 diabetes mellitus, and the risk of treatment-induced hypoglycemia should be carefully monitored. Although multiple treatment modalities are used in the treatment of chronic pancreatitis, the successful management of chronic pancreatitis relied on the good compliance of patient.

原文English
頁(從 - 到)190-194
頁數5
期刊Journal of Internal Medicine of Taiwan
27
發行號4
DOIs
出版狀態Published - 8月 2016

指紋

深入研究「The treatment of chronic pancreatitis」主題。共同形成了獨特的指紋。

引用此